葡萄糖类-1受体激动剂诱导的胆囊炎和胆病:使用FAERS数据库进行现实世界药监测分析
Chao Tao1,2, Yinhui Zhang1,2, Tenggang Wan3
1Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Frontiers in pharmacology
|July 23, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RA) 与胆囊问题,如胆囊炎和胆病有关. 这项药监测研究证实了显著的关联,强调了需要意识和管理策略的必要性.
科学领域:
- 药监和药物安全 药监和药物安全
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 在糖尿病和肥胖管理中广泛使用类似葡萄糖-1受体激动剂 (GLP-1RA).
- 越来越多的医疗保健专业人员对GLP-1RA诱导的胆囊炎和胆病的担忧.
研究的目的:
- 进行GLP-1 RA诱导的胆囊炎和胆病的综合药监测分析.
- 通过不成比例性分析识别和评估GLP-1RA与这些不良事件之间的关联.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 数据库 (2004年第一季度 - 2024年第二季度) 提取了不良事件报告.
- 使用的不成比例分析方法:报告几率比率 (ROR),比例报告比率 (PRR) 和贝叶斯信心传播神经网络 (BCPNN).
- 对五个常见的GLP-1RA进行了集中分析,无论是在高级级别还是首选期限级别.
主要成果:
- 确定了1,829份涉及1,651名患者的报告,其中GLP-1RA是主要的疑似药物.
- 这三种信号检测方法都证实了GLP-1RA与胆囊炎/胆病之间的积极关联.
- 大多数受影响的患者是45岁及以上的女性,平均发病时间为182天.
结论:
- 这项研究提供了强有力的证据,证明GLP-1 RA诱导的胆囊炎和胆病具有药监信号.
- 在临床实践中为预防和管理这些不良事件提供了宝贵的见解.
- 强调GLP-1RA持续监测和风险效益评估的重要性.
相关概念视频
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Glucagon-like Receptor Agonists
421
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
421
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Endoscopic Procedures V: ERCP
932
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
932
Acute Pancreatitis II: Clinical Manifestations and Management
177
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
177
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K


